Pfizer (PFE) Shares Outstanding (Diluted Average) (2016 - 2025)
Historic Shares Outstanding (Diluted Average) for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $5.7 billion.
- Pfizer's Shares Outstanding (Diluted Average) rose 15.78% to $5.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year increase of 15.78%. This contributed to the annual value of $5.7 billion for FY2024, which is 15.76% down from last year.
- According to the latest figures from Q3 2025, Pfizer's Shares Outstanding (Diluted Average) is $5.7 billion, which was up 15.78% from $5.7 billion recorded in Q2 2025.
- In the past 5 years, Pfizer's Shares Outstanding (Diluted Average) ranged from a high of $5.8 billion in Q2 2022 and a low of $5.7 billion during Q2 2021
- Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $5.7 billion (2025), whereas its average is $5.7 billion.
- As far as peak fluctuations go, Pfizer's Shares Outstanding (Diluted Average) surged by 169.55% in 2022, and later crashed by 53.84% in 2023.
- Quarter analysis of 5 years shows Pfizer's Shares Outstanding (Diluted Average) stood at $5.7 billion in 2021, then grew by 0.44% to $5.7 billion in 2022, then dropped by 0.42% to $5.7 billion in 2023, then decreased by 0.16% to $5.7 billion in 2024, then grew by 0.25% to $5.7 billion in 2025.
- Its last three reported values are $5.7 billion in Q3 2025, $5.7 billion for Q2 2025, and $5.7 billion during Q1 2025.